Profiling of plasma proteins in individuals with COVID-19 shows that complement activation and myeloid inflammation are major pathways in the pathogenesis of long COVID and identifies distinct profiles of immune dysregulation in individuals with long COVID, highlighting the heterogeneous and diverse nature of this disease.
References
Menges, D. et al. PloS ONE 16, e0254523 (2021).
Davis, H. E., McCorkell, L., Vogel, J. M. & Topol, E. J. Nat. Rev. Microbiol. 21, 133–146 (2023).
Liew, F. Nat. Immunol. https://doi.org/10.1038/s41590-024-01778-0 (2024).
Cervia-Hasler, C. et al. Science 383, eadg7942 (2024).
Chen, T., Gai, W.-P. & Abbott, C. A. BioMed Res. Int. 2014, e209398 (2014).
Qi, S. Y., Riviere, P. J., Trojnar, J., Junien, J.-L. & Akinsanya, K. O. Biochem. J. 373, 179–189 (2003).
Cervia, C. et al. J. Allergy Clin. Immunol. 147, 545–557.e9 (2021).
Acknowledgements
We thank T. Hoch and A. Nicoletto for reading the manuscript. Funding was provided by Swiss National Science Foundation grants (4078P0-198431, 310030-200669 and 310030-212240 to O.B.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
O.B. is listed as an inventor on a patent application (PCT/EP2023/084859) on biomarkers in long COVID. L.C. has no competing interests.
Rights and permissions
About this article
Cite this article
Ceglarek, L., Boyman, O. Immune dysregulation in long COVID. Nat Immunol 25, 587–589 (2024). https://doi.org/10.1038/s41590-024-01795-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-024-01795-z
- Springer Nature America, Inc.